Search filters

List of works by Lærke S Gasbjerg

Biased and constitutive signaling in the CC-chemokine receptor CCR5 by manipulating the interface between transmembrane helices 6 and 7.

scientific article published on 14 March 2013

Circulating Glucagon 1-61 Regulates Blood Glucose by Increasing Insulin Secretion and Hepatic Glucose Production

scientific article published in November 2017

Effect of Intracoronary and Intravenous Melatonin on Myocardial Salvage Index in Patients with ST-Elevation Myocardial Infarction: a Randomized Placebo Controlled Trial

scientific article

Effects of combined GIP and GLP-1 infusion on energy intake, appetite and energy expenditure in overweight/obese individuals: a randomised, crossover study

scientific article published on 25 January 2019

Extracellular disulfide bridges serve different purposes in two homologous chemokine receptors, CCR1 and CCR5.

scientific article published on 13 June 2013

GIP's effect on bone metabolism is reduced by the selective GIP receptor antagonist GIP(3-30)NH2

scientific article published on 14 October 2019

GIP(3-30)NH2 is an efficacious GIP receptor antagonist in humans: a randomised, double-blinded, placebo-controlled, crossover study

scientific article

GLP-2 and GIP exert separate effects on bone turnover: A randomized, placebo-controlled, crossover study in healthy young men

scientific article published on 15 May 2019

Gluco-metabolic effects of oral and intravenous alcohol administration in men

scientific article published on 01 October 2019

Glucose-dependent insulinotropic polypeptide (GIP) receptor antagonists as anti-diabetic agents

scientific article published in February 2018

Human GIP(3-30)NH2 inhibits G protein-dependent as well as G protein-independent signaling and is selective for the GIP receptor with high-affinity binding to primate but not rodent GIP receptors

scientific article published on 25 January 2018

Increased Body Weight and Fat Mass After Subchronic GIP Receptor Antagonist, but Not GLP-2 Receptor Antagonist, Administration in Rats

scientific article published on 06 August 2019

No Acute Effects of Exogenous Glucose-Dependent Insulinotropic Polypeptide on Energy Intake, Appetite, or Energy Expenditure When Added to Treatment With a Long-Acting Glucagon-Like Peptide 1 Receptor Agonist in Men With Type 2 Diabetes

scientific article published on 16 January 2020

Separate and Combined Effects of GIP and GLP-1 Infusions on Bone Metabolism in Overweight Men without Diabetes

scientific article published on 01 July 2019

Separate and Combined Glucometabolic Effects of Endogenous Glucose-Dependent Insulinotropic Polypeptide and Glucagon-like Peptide 1 in Healthy Individuals

scientific article published on 09 January 2019

Signaling via G proteins mediates tumorigenic effects of GPR87.

scientific article published on 16 November 2016

The Gluco- and Liporegulatory and Vasodilatory Effects of Glucose-Dependent Insulinotropic Polypeptide (GIP) Are Abolished by an Antagonist of the Human GIP Receptor

scientific article

The dose-dependent efficacy of the glucose-dependent insulinotropic polypeptide receptor antagonist, GIP(3-30)NH2 , on GIP actions in humans

scientific article published on 04 September 2020

Paulina is supported by:

About Paulina

Help